FALL RIVER, Mass., May 23, 2019 (GLOBE NEWSWIRE) -- Canna Care Docs, the largest and longest-running US-based medical clinic group specializing in cannabis evaluations and patient education, today announced the launch of its brand updates which includes a refreshed logo, new website and other identity marks. The updates reflect the brand’s commitment to patient care through comprehensive medical services and a focus on overall well being.
“This updated brand represents a significant milestone in our evolution as we continue to grow as the leading clinic group focused on medical cannabis serving 9 states across the US,” said Stephanie Gluchacki, President of Clinical Operations, Canna Care Docs. “Our new website will make it easier for our growing patient base of more than 65,000 patients annually to find us and interact with us as they seek out alternative therapies to bring about a greater sense of wellness.”
Canna Care Docs, a subsidiary of CB2 Insights, a leading healthcare technology company focused on mainstreaming cannabis into traditional healthcare through Real World Evidence, was established in 2013 and has provided comprehensive care to more than 300,000 patients since its inception. Currently, Canna Care Docs serves patients in Connecticut, Delaware, Illinois, Maine, Maryland, Massachusetts, New York, Pennsylvania and Rhode Island.
“Canna Care Docs has always represented comprehensive, compassionate and confidential care to hundreds of thousands of patients looking to integrate cannabinoid therapy into their treatment plan,” said Dan Thompson, Chief Marketing Officer, CB2 Insights. “We knew we needed a digital brand presence that matched the level of service that our patients find when they visit a Canna Care Docs in their area.”
Earlier this year, CB2 Insights acquired two additional clinic groups adding an additional 7 clinics in Colorado and Arizona. Canna Care Docs’ sister clinic groups will retain their individual brand identities – Relaxed Clarity and MedEval.
Canna Care Docs’ new logo and visual identity have already begun its rollout across its key digital properties, including cannacaredocs.com. The launch will continue through its nearly 30 physical locations throughout 2019.
About Canna Care Docs
Canna Care Docs is the largest and longest-running medical clinic group providing full-service cannabinoid therapy evaluations and education serving patients in nine states. CCD offers compliant service adhering to the medical frameworks of the communities in which it operates, helping new and existing patients gain legal access to medical cannabis. Since 2013, patients have received comprehensive cannabis-specific education and guidance, while connecting with a certifying physician. Canna Care Docs is a subsidiary of CB2 Insights. For more information visit www.cannacaredocs.com.
About CB2 Insights
CB2 Insights has a mission to mainstream medical cannabis into traditional healthcare. We do so by gathering data and creating objective real-world evidence through our proprietary software and service brands. Using clinical management and data collection software at the point-of-care, CB2 Insights and its group of sub-brands has become a leading force behind bringing traditional healthcare protocols to the rapidly evolving global cannabis industry.
For more information please visit www.cb2insights.com.
Primary Contact
Dan Thompson
1.416.670.9316
dan.thompson@cb2insights.com
For Investor Inquiries
Sophic Capital
1.647.362.8286
investors@cb2insights.com
For Media Inquiries:
KCSA Strategic Communications
cb2@kcsa.com
No securities regulator or exchange has reviewed, approved, disapproved, or accepts responsibility for the content of this news release.